Bilimsel Makale Arama | NeuralCipher AI

Kaynak kaydı

Improving the clinical trial landscape for Parkinson syndromes in Germany.

Höglinger G, Eggert K, Classen J, van Eimeren T, Höllerhage M, Jost WH, Kassubek J, Klucken J, Koeglsperger T, Krüger R, Müller T, Pötter-Nerger M, Riederer P, Storch A, Winkler J, Wüllner U, Schindler C, Lingor P, German Parkinson’s Experts Meeting Group.

J Neural Transm (Vienna) · 2026-10-24

DOI: 10.1007/s00702-026-03314-wPMID: 42925427

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Mitochondrial dysfunction in neurology: biomarkers and clinical implications.

Rossini E, Garibaldi M, Hanna MG, Pitceathly RDS, Pizzamiglio C.

Nat Rev Neurol · 2026-10-23

DOI: 10.1038/s41582-026-01274-zPMID: 42919989

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Remote Versus In-Person Follow-up Programming After Subthalamic Deep Brain Stimulation for Parkinson's Disease: A Multicenter Randomized Noninferiority Trial.

Shaik J, Zhang W, Zentsch V, Buhmann C, Hidding U, Kinfe TM, Regensburger M, Rumpf JJ, Schnitzler A, Dong J, Scherer M, Kaufmann E, Levin J, Crispin A, Höglinger G, Mehrkens JH, Koeglsperger T.

Mov Disord · 2026-10-23

DOI: 10.1002/mds.70575PMID: 42920097

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Neurodegenerative Diseases: Epidemiology, Risk Factors, Classification, Pathophysiology, Clinical Features, Diagnosis, and Therapeutic Strategies.

He Z, Zeng J, Wang G, Li Y, Zhang F.

MedComm (2020) · 2026-10-23

DOI: 10.1002/mco2.71090PMID: 42921272

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

The role of polysomnography in Parkinson's disease: objective sleep assessment and clinical indications.

Zanatta A, de Almeida CMO, Della Coletta MV, Teive HAG.

Arq Neuropsiquiatr · 2026-10-23

DOI: 10.1055/s-0046-1829160PMID: 42918254

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Odor-Specific Symptoms in Parkinson's Disease-UPSIT-TC Odor Identification Status Versus Clinical Severity.

Lin TC, Yang LY, Lin YH, Lei HB, Chiu SC, Fang TC, Chang MH, Guo YJ.

Parkinsons Dis · 2026-10-22

DOI: 10.1155/padi/9572752PMID: 42923752

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

MiR‑204‑5p modulates glial morphology and apomorphine‑induced rotational asymmetry without dopaminergic neuroprotection in a preclinical mouse model of Parkinson's disease.

Serra-Almeida C, Vale A, Tomé-Ribeiro I, Barão M, Cristóvão AC, Ferreira L, Bernardino L.

Metab Brain Dis · 2026-10-22

DOI: 10.1007/s11011-026-02012-6PMID: 42911300

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

AI-Powered Structuring of Clinical Information in Parkinson's Disease: An Approach Based on Large Language Models.

Zalabarria U, Saenz A, Ochoa A, Pino RD, Gabilondo I, Gomez-Esteban JC, Tijero B, Seijo S.

IEEE J Biomed Health Inform · 2026-10-21

DOI: 10.1109/jbhi.2026.3746031PMID: 42905578

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Psilocybin and Inflammatory and Mitochondrial Stress Markers in Parkinson Disease: A Nonrandomized Clinical Trial.

Bradley ER, Kelley P, Szigeti B, Nishimi K, Picard M, Sakai K, Fernandes-Osterhold G, Ostrem JL, Tanner CM, Ludwig C, Llerena K, Finley PR, Busby Z, McKernan A, Pantoni MM, Penn AD, Wang ACC, Zuzuarregui JRP, Woolley JD, O'Donovan A.

JAMA Psychiatry · 2026-10-21

DOI: 10.1001/jamapsychiatry.2026.2733PMID: 42905733

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Pharmacological Activities of Centella asiatica: A Systematic Review of Preclinical and Clinical Evidence on Cardiovascular, Neurological, Antioxidant, and Anti-inflammatory Effects.

Yuwadee A, Boonprasert K, Na-Bangchang K.

Planta Med · 2026-10-21

DOI: 10.1055/a-2969-6239PMID: 42906579

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Depression in the prodromal phase of Parkinson's disease: Clinical manifestations, biomarker evidence, and predictive implications.

Zhou ZD, Elvira R, Ng JH, Tamakoshi D, Hiraga K, Xiao B, Katsuno M, Tan EK.

Parkinsonism Relat Disord · 2026-10-21

DOI: 10.1016/j.parkreldis.2026.109023PMID: 42907235

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Computerized fine motor assessment in Parkinson's Disease: Task-specific measures provide complementary clinical information.

Menteşe B, Savran FN, Batum M, Kutlu N.

Neurol Sci · 2026-10-20

DOI: 10.1007/s10072-026-09482-7PMID: 42897313

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

7.691 makale bulundu

Improving the clinical trial landscape for Parkinson syndromes in Germany.

Mitochondrial dysfunction in neurology: biomarkers and clinical implications.

Remote Versus In-Person Follow-up Programming After Subthalamic Deep Brain Stimulation for Parkinson's Disease: A Multicenter Randomized Noninferiority Trial.

Neurodegenerative Diseases: Epidemiology, Risk Factors, Classification, Pathophysiology, Clinical Features, Diagnosis, and Therapeutic Strategies.

The role of polysomnography in Parkinson's disease: objective sleep assessment and clinical indications.

Odor-Specific Symptoms in Parkinson's Disease-UPSIT-TC Odor Identification Status Versus Clinical Severity.

MiR‑204‑5p modulates glial morphology and apomorphine‑induced rotational asymmetry without dopaminergic neuroprotection in a preclinical mouse model of Parkinson's disease.

AI-Powered Structuring of Clinical Information in Parkinson's Disease: An Approach Based on Large Language Models.

Psilocybin and Inflammatory and Mitochondrial Stress Markers in Parkinson Disease: A Nonrandomized Clinical Trial.

Pharmacological Activities of Centella asiatica: A Systematic Review of Preclinical and Clinical Evidence on Cardiovascular, Neurological, Antioxidant, and Anti-inflammatory Effects.

Depression in the prodromal phase of Parkinson's disease: Clinical manifestations, biomarker evidence, and predictive implications.

Computerized fine motor assessment in Parkinson's Disease: Task-specific measures provide complementary clinical information.

Filtreler